First-In-Human Study of CU06-1004 Following Single and Multiple Ascending Doses in Healthy Volunteers

NCT04795037 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

81

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetic Macular Edema

Interventions

DRUG: CU06-1004, Single dose
DRUG: CU06-1004, Multiple doses
DRUG: Placebo

Sponsor

Curacle Co., Ltd.

Collaborators

[object Object]